Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cosmos HealthCOSM +3.49%29 Equity-to-Asset is 0.32 as of Mar. 2026, which is 540% above its 10-year median of 0.05. GuruFocus rates COSM with a GF Score™ of 29/100 and a GF Value™ of $0.35 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 119 Medical Distribution companies, Cosmos Health ranks worse than 64.71% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cosmos Health's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $19.83 Mil. Cosmos Health's Total Assets for the quarter that ended in Mar. 2026 was $62.37 Mil.
Therefore, Cosmos Health's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.32.
The historical rank and industry rank for Cosmos Health's Equity-to-Asset or its related term are showing as below:
COSM'
s Equity-to-Asset Range Over the Past 10 Years
Min: -1.63 Med: 0.05 Max: 0.65
Current: 0.32
During the past 13 years, the highest Equity to Asset Ratio of Cosmos Health was 0.65. The lowest was -1.63. And the median was 0.05.
COSM's Equity-to-Asset is ranked worse than 64.71% of 119
companies
in the Medical Distribution industry
Industry Median: 0.39
vs COSM: 0.32
Cosmos Health (NAS:COSM) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Cosmos Health Equity-to-Asset Related Terms
Cosmos Health Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Cosmos Health's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSM vs HKPD, SNYR, YI: Equity-to-Asset Comparison
For the Medical Distribution subindustry, Cosmos Health's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cosmos Health Equity-to-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cosmos Health's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Cosmos Health's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Cosmos Health's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cosmos Health (COSM) has a Equity-to-Asset of 0.32 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Cosmos Health and its competitors. This is 540% above median its historical median of 0.05. According to the industry distribution chart, Cosmos Health ranks #77 out of 119 companies in the Medical Distribution industry, placing it in the top 64.7%.
Is Cosmos Health's Equity-to-Asset too high?
Cosmos Health's current Equity-to-Asset of 0.32 is 540% above median its 10-year median of 0.05. The Medical Distribution industry median Equity-to-Asset is 0.39. Cosmos Health's value of 0.32 is 17.9% below this industry median. Based on the distribution chart, Cosmos Health ranks #77 out of 119 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Cosmos Health has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cosmos Health's Equity-to-Asset compare to HKPD and SNYR?
According to the Medical Distribution industry distribution chart, Cosmos Health ranks #77 out of 119 companies for Equity-to-Asset. This places Cosmos Health in the lower half of its industry. The industry median Equity-to-Asset is 0.39. Cosmos Health's value of 0.32 is 17.9% below this benchmark. While the company's 10-year median is 0.05 vs. the industry median of 0.39, Cosmos Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Distribution company?
The median Equity-to-Asset among Medical Distribution companies is 0.39, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cosmos Health's current Equity-to-Asset of 0.32 is 17.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Cosmos Health and its competitors. For the Medical Distribution industry, the median Equity-to-Asset is 0.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmos Health's current Equity-to-Asset is 0.32, which is 540% above median its own 10-year median of 0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmos Health stock overvalued right now?
Based on GuruFocus' analysis, Cosmos Health (COSM) is currently considered Possible Value Trap. The stock's GF Value™ is $0.35, compared to a current price of $0.22 — trading 38.1% below its estimated fair value. The current Equity-to-Asset is 0.32, which is 540% above median its 10-year median of 0.05 and 17.9% below the Medical Distribution industry median of 0.39. Cosmos Health's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Cosmos Health (COSM), the current Equity-to-Asset is 0.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cosmos Health (COSM) Overvalued in 2026?
Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued.
The current stock price of $0.22 is trading 38.1% below its estimated GF Value™ of $0.35.
GuruFocus considers Cosmos Health to be Possible Value Trap.
Key valuation signals for COSM:
Equity-to-Asset: 0.32 (540% above median its 10-year median of 0.05)
GF Value™: $0.35 vs. price of $0.22 (38.1% below fair value)
Industry Position: 17.9% below the Medical Distribution median (#77 of 119)
No single metric tells the full story. See the COSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
29GF Score
Get the complete analysis for COSM
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COSM has been successfully added to your 
